0.00
price down icon100.00%   -0.88
after-market Dopo l'orario di chiusura: .88 0.88 +
loading
Precedente Chiudi:
$0.88
Aprire:
$0
Volume 24 ore:
0
Relative Volume:
0.00
Capitalizzazione di mercato:
$54.26M
Reddito:
-
Utile/perdita netta:
$-112.67M
Rapporto P/E:
0.00
EPS:
-1.95
Flusso di cassa netto:
$-79.26M
1 W Prestazione:
-100.00%
1M Prestazione:
-100.00%
6M Prestazione:
-100.00%
1 anno Prestazione:
-100.00%
Intervallo 1D:
Value
$0.00
$0.00
Intervallo di 1 settimana:
Value
$0.00
$0.00
Portata 52W:
Value
$0.00
$1.60

Kronos Bio Inc Stock (KRON) Company Profile

Name
Nome
Kronos Bio Inc
Name
Telefono
(650) 781-5200
Name
Indirizzo
1300 S. EL CAMINO REAL, SAN MATEO
Name
Dipendente
8
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-11
Name
Ultimi documenti SEC
Name
KRON's Discussions on Twitter

Confronta KRON con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
KRON
Kronos Bio Inc
0.00 54.26M 0 -112.67M -79.26M -1.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
441.30 115.95B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
521.00 56.52B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
322.83 39.44B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
560.14 35.14B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
241.20 28.51B 3.81B -644.79M -669.77M -6.24

Kronos Bio Inc Stock (KRON) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2024-11-14 Downgrade Piper Sandler Overweight → Neutral
2024-11-14 Downgrade TD Cowen Buy → Hold
2022-09-14 Iniziato Berenberg Buy
2021-10-20 Ripresa Cowen Outperform
2021-06-24 Iniziato H.C. Wainwright Buy
2020-11-03 Iniziato Cowen Outperform
2020-11-03 Iniziato Goldman Buy
2020-11-03 Iniziato Jefferies Buy
2020-11-03 Iniziato Piper Sandler Overweight
Mostra tutto

Kronos Bio Inc Borsa (KRON) Ultime notizie

pulisher
Jun 18, 2025

Market Momentum Report: Kronos Bio Inc (KRON)’s Negative Close at 0.88 - DWinneX

Jun 18, 2025
pulisher
Jun 14, 2025

Two Sigma Investments LP Cuts Stock Holdings in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World

Jun 14, 2025
pulisher
Jun 10, 2025

Kronos Bio to Exit Cambridge Lab, Returning Prime Space to Market Amid Biotech Downturn, Reports BBJ - Boston Real Estate Times

Jun 10, 2025
pulisher
Jun 10, 2025

Squarepoint Ops LLC Makes New $93,000 Investment in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World

Jun 10, 2025
pulisher
Jun 05, 2025

Kronos Bio sends Cambridge lab space back to market - The Business Journals

Jun 05, 2025
pulisher
Jun 05, 2025

Kronos Bio Reports Third Quarter 2024 Financial Results and Corporate Update Including Plan to Evaluate Strategic Alternatives - mx.advfn.com

Jun 05, 2025
pulisher
Jun 05, 2025

kronos bio ends lease early, expects cost savings - Investing.com

Jun 05, 2025
pulisher
Jun 05, 2025

Kronos Bio Terminates Cambridge Lease Agreement - TipRanks

Jun 05, 2025
pulisher
Jun 05, 2025

Kronos Bio IncTerminates Office Lease At 301 Binney StreetSEC Filing - MarketScreener

Jun 05, 2025
pulisher
Jun 03, 2025

Millennium Management LLC Has $1.63 Million Holdings in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World

Jun 03, 2025
pulisher
May 22, 2025

Shareholders Filed a Lawsuit Against Kronos Bio for Merger Disclosure Failures - TradingView

May 22, 2025
pulisher
May 22, 2025

Kronos Bio ($KRON) Misleading Merger Proxy and Insider Enrichment Case - TradingView

May 22, 2025
pulisher
May 21, 2025

Kronos Bio Shareholder Says Sale Unfairly Benefits Execs - Law360

May 21, 2025
pulisher
May 21, 2025

Kronos Bio, Board Sued by Shareholder Over Concentra Buyout Deal - Bloomberg Law News

May 21, 2025
pulisher
May 18, 2025

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AXL, KRON, PRA, SWTX on Behalf of Shareholders - GlobeNewswire Inc.

May 18, 2025
pulisher
May 16, 2025

STOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The Merger - Benzinga

May 16, 2025
pulisher
May 15, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire

May 15, 2025
pulisher
May 15, 2025

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Kronos Bio, Inc. (NasdaqKRON), Regulus Therapeutics Inc. (Nasdaq – RGLS), Longevity Health Holdings, Inc. (NasdaqXAGE), Southern States Bancshare - TradingView

May 15, 2025
pulisher
May 13, 2025

Kronos Bio discovers p300 inhibitors - BioWorld MedTech

May 13, 2025
pulisher
May 10, 2025

Weekly CEO Buys Highlight - GuruFocus

May 10, 2025
pulisher
May 05, 2025

Deal Watch: Lilly Looks To Creyon For Oligonucleotides - insights.citeline.com

May 05, 2025
pulisher
May 05, 2025

Concentra Biosciences Agrees to Acquire Kronos Bio - Contract Pharma

May 05, 2025
pulisher
May 04, 2025

KRONOS BIO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Kronos Bio, Inc.KRON - Business Wire

May 04, 2025
pulisher
May 02, 2025

KRON Shares Experience Decline in Value - knoxdaily.com

May 02, 2025
pulisher
May 02, 2025

why Kronos Bio Inc [KRON] is a Good Choice for Investors After New Price Target of $1.00 - dbtnews.com

May 02, 2025
pulisher
May 02, 2025

Kronos shares slump on Concentra takeover news - The Pharma Letter

May 02, 2025
pulisher
May 01, 2025

Kronos Bio (KRON) to Merge with Concentra Biosciences in $0.57 P - GuruFocus

May 01, 2025
pulisher
May 01, 2025

SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger of Kronos Bio, Inc.KRON - PR Newswire

May 01, 2025
pulisher
May 01, 2025

Struggling Peninsula biotech with Gilead lineage is latest purchase for activist investorSan Francisco Business Times - The Business Journals

May 01, 2025
pulisher
May 01, 2025

Now Is The Time To Build A Position In Kronos Bio Inc (NASDAQ:KRON) - Marketing Sentinel

May 01, 2025
pulisher
May 01, 2025

KRON’s Stock Market Labyrinth: Navigating 2023’s Gains and Declines - investchronicle.com

May 01, 2025
pulisher
May 01, 2025

Kronos Bio Enters Deal to be Acquired by Concentra Biosciences; Shares Fall - marketscreener.com

May 01, 2025
pulisher
May 01, 2025

Today’s watch list includes Kronos Bio Inc (NASDAQ:KRON) stock - uspostnews.com

May 01, 2025
pulisher
May 01, 2025

Kronos Bio stock hits 52-week low at $0.68 amid market challenges - Investing.com India

May 01, 2025
pulisher
May 01, 2025

After hunt for alternatives, Kronos Bio selects Tang Capital’s Concentra for a deal - Endpoints News

May 01, 2025
pulisher
May 01, 2025

Kronos Bio (KRON) to be Acquired by Concentra Biosciences in Strategic Merger | KRON Stock News - GuruFocus

May 01, 2025
pulisher
May 01, 2025

Shareholder Alert: The Ademi Firm Investigates Whether Kronos Bio, Inc. is Obtaining a Fair Price for Its Public Shareholders - The Joplin Globe

May 01, 2025
pulisher
May 01, 2025

KRON Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Kronos Bio, Inc. Is Fair to Shareholders - The Joplin Globe

May 01, 2025
pulisher
May 01, 2025

Concentra To Acquire Kronos Bio - Nasdaq

May 01, 2025
pulisher
May 01, 2025

Kronos Bio Enters into Agreement to Be Acquired by Concentra Biosciences for $0.57 in Cash per Share Plus a Contingent Value Right - The Manila Times

May 01, 2025
pulisher
May 01, 2025

Kronos Bio agrees to Concentra Biosciences acquisition - Investing.com

May 01, 2025
pulisher
May 01, 2025

Kronos Bio Enters into Agreement to Be Acquired by - GlobeNewswire

May 01, 2025
pulisher
May 01, 2025

Kronos Bio (KRON) Projected to Announce Quarterly Earnings on Thursday - Defense World

May 01, 2025
pulisher
Apr 30, 2025

Renaissance Technologies LLC Has $1.11 Million Position in Kronos Bio, Inc. (NASDAQ:KRON) - Defense World

Apr 30, 2025
pulisher
Apr 11, 2025

Kronos Bio ends lease early, pays $1.4 million settlement - Investing.com Australia

Apr 11, 2025
pulisher
Apr 10, 2025

Kronos Bio ends lease early, pays $1.4 million settlement By Investing.com - Investing.com Canada

Apr 10, 2025
pulisher
Apr 10, 2025

Kronos Bio Announces Lease Termination Agreement - TipRanks

Apr 10, 2025
pulisher
Apr 10, 2025

Ottimo Pharma Strengthens Board with Appointment of Roger Dansey, M.D. to its Board of Directors - The Manila Times

Apr 10, 2025
pulisher
Mar 28, 2025

Layoff Tracker: BioAtla Streamlines Operations By Cutting 30% of Staff - BioSpace

Mar 28, 2025
pulisher
Mar 26, 2025

Kronos Bio Reports 2024 Financial Results - TipRanks

Mar 26, 2025

Kronos Bio Inc Azioni (KRON) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$20.50
price down icon 1.11%
$35.87
price up icon 1.70%
$20.60
price down icon 3.38%
$99.49
price down icon 2.21%
$106.72
price up icon 0.55%
biotechnology ONC
$241.20
price down icon 5.22%
Capitalizzazione:     |  Volume (24 ore):